PIK3CA and neoplasm: When testing for PIK3CA mutations in ABC, various factors should be considered by pathologists and oncologists, including choice of assay, sample availability, sample collection and preparation, time of screening, and tumor heterogeneity and evolution.14, 16, 31, 44